Background: Voiding dysfunction (VD) is a potential complication after female midurethral sling operations. Objectives: Our goal was to assess the rate of obstructive VD after -transobturator tension-free tape (TOT) procedures and to find perioperative risk factors (RFs) predicting postoperative voiding problems. Methods: We have retrospectively evaluated the perioperative data of 397 women who underwent TOT operations. Significant post-void residual (PVR) (>50 mL) was considered as the primary (objective) end point of the study, the voiding difficulty as the secondary (subjective) 1. First univariate analysis and then multivariate logistic regression were performed, with a 5% significance level. Results: Significant PVR was present in 51 (12.8%) women; catheterization was needed in 21 (5.3%) and reoperation in 3 (0.8%) cases. Seventy women (17.6%) experienced postoperative voiding difficulty. Narrow vagina (<2 cm), older age >70 years, and preoperative voiding difficulty were independent RFs for significant PVR (odds ratio: 5.07, 2.14, 5.38, respectively, p < 0.05). Preoperative overactive bladder syndrome and previous pelvic organ prolapse surgery were considered independent RFs for postoperative voiding difficulty. Conclusions: Older age, narrow vagina, or preoperative voiding difficulty increases the chance for significant postoperative PVR. These patients should be chosen and counseled appropriately.

1.
FitzGerald
MP
,
Elliott
C
,
Brubaker
L
.
New vs. old: descriptors can affect patients’ surgical preferences
.
Am J Obstet Gynecol
.
2008
;
199
(
5
):
476.e1
3
.
2.
Novara
G
,
Ficarra
V
,
Boscolo-Berto
R
,
Secco
S
,
Cavalleri
S
,
Artibani
W
.
Tension-free midurethral slings in the treatment in female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials of effectiveness
.
Eur Urol
.
2007
;
52
(
3
):
663
78
.
3.
Abrams
P
,
Cradozo
L
,
Wagg
A
,
Wein
A
.
Incontinence
. 6th ed.
ICUD ICS
;
2017
. ISBN: 978–0–9569607–3–3.
4.
Rogerson
L
,
Cody
JD
,
Aluko
P
,
Ogah
JA
.
Mid-urethral sling operations for stress urinary incontinence in women
.
Cochrane Database Syst Rev
.
2017
;
7
:
CD006375
.
5.
Burkhard
FC
,
Bosch
JLHR
,
Cruz
F
,
Lemack
GE
,
Nambiar
AK
,
Thiruchelvam
N
,
European association of urology guidelines 2020: urinary incontinence
;
2020
. ISBN: 978–94–92671–07–3.
6.
Ashok
K
,
Petri
E
.
Failures and complications in pelvic floor surgery (2012)
.
World J Urol
.
2020
;
30
:
487
94
.
7.
Sokol
AI
,
Jelovsek
JE
,
Walters
MD
,
Paraiso
MF
,
Barber
MD
.
Incidence and predictors of prolonged urinary retention after TVT with and without concurrent prolapse surgery
.
Am J Obstet Gynecol
.
2005
;
192
:
1537
43
. .
8.
Morey
AF
,
Medendorp
AR
,
Noller
MW
,
Mora
RV
,
Shandera
KC
,
Foley
JP
,
Transobturator versus transabdominal mid urethral slings: a multi-institutional comparison of obstructive voiding complications
.
J Urol
.
2006
;
175
(
3
):
1014
7
. .
9.
Kim
JW
,
Moon
du G
,
Shin
JH
,
Bae
JH
,
Lee
JG
,
Oh
MM
.
Predictors of voiding dysfunction after mid-urethral sling surgery for stress urinary incontinence
.
Int Neurourol J
.
2012
;
16
(
1
):
30
6
. .
10.
Novara
G
,
Galfano
A
,
Boscolo-Berto
R
,
Secco
S
,
Cavalleri
S
,
Ficarra
V
,
Complication rates of tension-free midurethral slings in the treatment of female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials comparing tension-free midurethral tapes to other surgical procedures and different devices
.
Eur Urol
.
2008
;
53
(
2
):
288
308
. .
11.
Abouassaly
R
,
Steinberg
JR
,
Lemieux
M
,
Marois
C
,
Gilchrist
LI
,
Bourque
JL
,
Complications of tension-free vaginal tape surgery: a multi-institutional review
.
BJU Int
.
2004
;
94
:
110
3
. .
12.
Vervest
HA
,
Bisseling
TM
,
Heintz
AP
,
Schraffordt Koops
SE
.
The prevalence of voiding difficulty after TVT, its impact on quality of life, and related risk factors
.
Int Urogynecol J Pelvic Floor Dysfunct
.
2007
;
18
:
173
82
. .
13.
Al-Badr
A
,
Ross
S
,
Soroka
D
,
Minassian
VA
,
Karahalios
A
,
Drutz
HP
.
Voiding patterns and urodynamics after a tension-free vaginal tape procedure
.
J Obstet Gynaecol Can
.
2003
;
25
(
9
):
725
30
. .
14.
The international consultation on benign prostatic hyperplasia
.
Paris, France
:
World Health Organization
;
1991
. ISBN 2905744111.
15.
Uebersax
JS
,
Wyman
JF
,
Shumaker
SA
,
McClish
DK
,
Fantl
JA
.
Short forms to assess life quality and symptom distress for urinary incontinence in women the incontinence impact questionnaire and the urogenital distress inventory. Continence Program for Women Research Group
.
Neurourol Urodyn
.
1995
;
14
(
2
):
131
9
.
16.
Ballester
M
,
Bui
C
,
Frobert
JL
,
Grisard-Anaf
M
,
Lienhart
J
,
Fernandez
H
,
Four-year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomised multicenre study comparing the retropubic and transobturator routes
.
World J Urol
.
2012
;
30
:
117
22
.
17.
Phé
V
,
Zimmern
P
,
Chartier-Kastler
E
.
Outcome measures for stress urinary incontinence treatment: can we minimally agree?
World J Urol
.
2015
;
33
:
1221
34
. .
18.
Chung
SM
,
Moon
YJ
,
JeonKim
MJSK
,
Kim
SK
,
Bai
SW
.
Risk factors associated with voiding dysfunction after anti-incontinence surgery
.
Int Urogynecol J
.
2010
;
21
:
1505
9
. .
19.
Celik
F
,
Pektas
MK
,
Kose
M
,
Arioz
DT
,
Yesildager
E
,
Yilmazer
M
.
Two-year follow-up results of transobturator tape procedure with and without concomitant vaginal surgery
.
Urol Int
.
2018
;
100
:
402
8
. .
20.
Stav
K
,
Dwyer
PL
,
Rosamilia
A
,
Schierlitz
L
,
Lim
YN
,
Lee
J
.
Midurethral sling procedures for stress urinary incontinence in women over 80 years
.
Neurourol Urodyn
.
2010
;
29
:
1262
6
. .
21.
Kim
JH
,
Shin
SH
,
Oh
MM
,
Park
JY
,
Lee
JG
,
Bae
JH
.
Factors affecting transient urinary retention after transobturator tape mid-urethral sling surgery for female patients with stress urinary incontinence: a single center experience
.
Eur J Obstet Gynecol Reprod Biol
.
2013
;
168
(
1
):
107
11
. .
22.
Chai
C
,
Kenton
K
,
Xu
Y
,
Sirls
L
,
Zyczynski
H
,
Wilson
TS
,
Effects of concomitant surgeries during mid-urethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables
.
Urology
.
2012
;
79
(
6
):
1256
61
.
23.
Natale
F
,
La Penna
C
,
Saltari
M
,
Piccione
E
,
Cervigni
M
.
Voiding dysfunction after anti-incontinence surgery
.
Minerva Ginecol
.
2009
;
61
:
167
72
.
24.
Ripperda
CM
,
Kowalski
JT
,
Chaudhry
ZQ
,
Mahal
AS
,
Lanzer
J
,
Noor
N
,
Predictors of early postoperative voiding dysfunction and other complications following a midurethral sling
.
Am J Obstet Gynecol
.
2016 Nov
;
215
(
5
):
656.e1
6
. .
25.
Reich
A
,
Kohorst
F
,
Kreienberg
R
,
Flock
F
.
Voiding dysfunction after the tension-free vaginal tape procedure
.
Gynecol Obstet Invest
.
2011
;
72
:
79
84
. .
26.
Tarcen
T
,
Mangir
N
,
Sahan
A
,
Tanidir
Y
,
Sulukaya
M
,
Ilker
Y
.
Safety and Efficacy of retropubic or transobturator midurethral slings in a randomized cohort of Turkish women
.
Urol Int
.
2014
;
93
:
449
53
.
27.
FitzGerald
MP
,
Brubaker
L
.
The etiology of urinary retention after surgery for genuine stress incontinence
.
Neurourol Urodyn
.
2001
;
20
:
13
21
. .
28.
Weinberger
MW
,
Ostergard
DR
.
Postoperative catheterization, urinary retention, and permanent voiding dysfunction after polytetrafluroethylene suburethral sling placement
.
Obstet Gynecol
.
1996
;
87
(
1
):
50
4
. .
29.
Pereira e Silva
R
,
Gomes Olival
V
,
Ponte
C
,
Palma Dos Reis
J
,
Colaço
J
,
Grilo
I
,
Overactive bladder symptoms after transobturator sling surgery for pure stress urinary incontinence: a cross-sectional comparative study
.
Urol Int
.
2018
;
100
(
4
):
428
33
. .
30.
Chang
A
,
Jungbum
B
,
Kwang
SL
,
Hae
WL
.
Analysis of voiding dysfunction after transobturator tape procedure for stress urinary incontinence
.
Korean J Urol
.
2015
;
56
:
823
30
.
31.
Balzarro
M
,
Rubilotta
E
,
Goss
C
,
Costantini
E
,
Artibani
W
,
Sand
P
.
Counseling in urogynecology: a difficult task, or simply good surgeon–patient communication?
Int Urogynecol J
.
2018
;
29
:
943
8
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.